SEC Form D · Amendment · filed August 20, 2021
AmbAgon Therapeutics Inc
Location
SAN FRANCISCO, CA
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (33)
Margarita Chavez · San Francisco, CADirectorScott Clarke · San Francisco, CAExec · DirectorRoel Bulthuis · San Francisco, CADirectorJosh Seidenfeld · San Francisco, CAExecPeter Dudek · San Francisco, CADirectorChristian Ottmann · San Francisco, CAExecJanwillem Naesens · San Francisco, CADirectorBryan Miller · San Francisco, CAExecMichelle Arkin · San Francisco, CADirectorNancy Pryer · San Francisco, CAExecAdam Rosenberg · San Francisco, CADirectorAndreas P. Emmanuel · Dallas, TXExec · DirectorDonald R. Young · Northborough, MADirectorJ. E. Virtue · New York, NYDirectorJ. D. Plants · San Francisco, CAExecYaniv Tepper · Los Angeles, CADirectorSteven R. Mitchell · Northborough, MADirectorLawrence J. Konis · Santa Monica, CAExecAndrew E. Spring · New York, NYDirectorKendall J. Saville · Dallas, TXExecAjay Gupta · CHRISTCHURCH, Q2DirectorMichael R. Wittmeyer · Dallas, TXExecMamoon Hamid · San Francisco, CADirectorJoshua Merrill · San Francisco, CAExecCraig Kautsch · Fort Worth, TXDirectorRichard Wahlstedt · Chicago, ILDirectorJoseph King · Chicago, ILDirectorMark D. Allsteadt · NORWALK, CTDirectorDavid Festi · Washington, PADirectorEdward Engler · Pittsburgh, PAExecKenneth Martin · Pittsburgh, PAExecRobert Kornblum · Pittsburgh, PAExecHarpoon Ventures Iv GP, LLC · CORONADO, CAExec · Director Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗